221 related articles for article (PubMed ID: 29679010)
1. Genetically engineered two-warhead evasins provide a method to achieve precision targeting of disease-relevant chemokine subsets.
Alenazi Y; Singh K; Davies G; Eaton JRO; Elders P; Kawamura A; Bhattacharya S
Sci Rep; 2018 Apr; 8(1):6333. PubMed ID: 29679010
[TBL] [Abstract][Full Text] [Related]
2. A knottin scaffold directs the CXC-chemokine-binding specificity of tick evasins.
Lee AW; Deruaz M; Lynch C; Davies G; Singh K; Alenazi Y; Eaton JRO; Kawamura A; Shaw J; Proudfoot AEI; Dias JM; Bhattacharya S
J Biol Chem; 2019 Jul; 294(29):11199-11212. PubMed ID: 31167786
[TBL] [Abstract][Full Text] [Related]
3. Phylogenetic Analysis Indicates That Evasin-Like Proteins of Ixodid Ticks Fall Into Three Distinct Classes.
Bhattacharya S; Nuttall PA
Front Cell Infect Microbiol; 2021; 11():769542. PubMed ID: 34746035
[TBL] [Abstract][Full Text] [Related]
4. The N-terminal domain of a tick evasin is critical for chemokine binding and neutralization and confers specific binding activity to other evasins.
Eaton JRO; Alenazi Y; Singh K; Davies G; Geis-Asteggiante L; Kessler B; Robinson CV; Kawamura A; Bhattacharya S
J Biol Chem; 2018 Apr; 293(16):6134-6146. PubMed ID: 29487134
[TBL] [Abstract][Full Text] [Related]
5. Engineering broad-spectrum inhibitors of inflammatory chemokines from subclass A3 tick evasins.
Devkota SR; Aryal P; Pokhrel R; Jiao W; Perry A; Panjikar S; Payne RJ; Wilce MCJ; Bhusal RP; Stone MJ
Nat Commun; 2023 Jul; 14(1):4204. PubMed ID: 37452046
[TBL] [Abstract][Full Text] [Related]
6. Yeast surface display identifies a family of evasins from ticks with novel polyvalent CC chemokine-binding activities.
Singh K; Davies G; Alenazi Y; Eaton JRO; Kawamura A; Bhattacharya S
Sci Rep; 2017 Jun; 7(1):4267. PubMed ID: 28655871
[TBL] [Abstract][Full Text] [Related]
7. Structure-guided engineering of tick evasins for targeting chemokines in inflammatory diseases.
Bhusal RP; Aryal P; Devkota SR; Pokhrel R; Gunzburg MJ; Foster SR; Lim HD; Payne RJ; Wilce MCJ; Stone MJ
Proc Natl Acad Sci U S A; 2022 Mar; 119(9):. PubMed ID: 35217625
[TBL] [Abstract][Full Text] [Related]
8. Structural basis of chemokine recognition by the class A3 tick evasin EVA-ACA1001.
Devkota SR; Aryal P; Wilce MCJ; Payne RJ; Stone MJ; Bhusal RP
Protein Sci; 2024 Jun; 33(6):e4999. PubMed ID: 38723106
[TBL] [Abstract][Full Text] [Related]
9. The role of CXC chemokines and their receptors in cancer.
Vandercappellen J; Van Damme J; Struyf S
Cancer Lett; 2008 Aug; 267(2):226-44. PubMed ID: 18579287
[TBL] [Abstract][Full Text] [Related]
10. Evasins: Tick Salivary Proteins that Inhibit Mammalian Chemokines.
Bhusal RP; Eaton JRO; Chowdhury ST; Power CA; Proudfoot AEI; Stone MJ; Bhattacharya S
Trends Biochem Sci; 2020 Feb; 45(2):108-122. PubMed ID: 31679840
[TBL] [Abstract][Full Text] [Related]
11. Swapping N-terminal regions among tick evasins reveals cooperative interactions influencing chemokine binding and selectivity.
Aryal P; Devkota SR; Jeevarajah D; Law R; Payne RJ; Bhusal RP; Stone MJ
J Biol Chem; 2022 Oct; 298(10):102382. PubMed ID: 35973511
[TBL] [Abstract][Full Text] [Related]
12. Molecular cloning of a novel human CC chemokine liver and activation-regulated chemokine (LARC) expressed in liver. Chemotactic activity for lymphocytes and gene localization on chromosome 2.
Hieshima K; Imai T; Opdenakker G; Van Damme J; Kusuda J; Tei H; Sakaki Y; Takatsuki K; Miura R; Yoshie O; Nomiyama H
J Biol Chem; 1997 Feb; 272(9):5846-53. PubMed ID: 9038201
[TBL] [Abstract][Full Text] [Related]
13. Blockade of chemokine activity by a soluble chemokine binding protein from vaccinia virus.
Alcamí A; Symons JA; Collins PD; Williams TJ; Smith GL
J Immunol; 1998 Jan; 160(2):624-33. PubMed ID: 9551896
[TBL] [Abstract][Full Text] [Related]
14. Ticks from diverse genera encode chemokine-inhibitory evasin proteins.
Hayward J; Sanchez J; Perry A; Huang C; Rodriguez Valle M; Canals M; Payne RJ; Stone MJ
J Biol Chem; 2017 Sep; 292(38):15670-15680. PubMed ID: 28778927
[TBL] [Abstract][Full Text] [Related]
15. Campylobacter jejuni-mediated induction of CC and CXC chemokines and chemokine receptors in human dendritic cells.
Hu L; Bray MD; Geng Y; Kopecko DJ
Infect Immun; 2012 Aug; 80(8):2929-39. PubMed ID: 22689814
[TBL] [Abstract][Full Text] [Related]
16. Evasin-displaying lactic acid bacteria bind different chemokines and neutralize CXCL8 production in Caco-2 cells.
Škrlec K; Pucer Janež A; Rogelj B; Štrukelj B; Berlec A
Microb Biotechnol; 2017 Nov; 10(6):1732-1743. PubMed ID: 28736998
[TBL] [Abstract][Full Text] [Related]
17. CXC and CC chemokines as angiogenic modulators in nonhaematological tumors.
Santoni M; Bracarda S; Nabissi M; Massari F; Conti A; Bria E; Tortora G; Santoni G; Cascinu S
Biomed Res Int; 2014; 2014():768758. PubMed ID: 24971349
[TBL] [Abstract][Full Text] [Related]
18. Structures of Orf Virus Chemokine Binding Protein in Complex with Host Chemokines Reveal Clues to Broad Binding Specificity.
Couñago RM; Knapp KM; Nakatani Y; Fleming SB; Corbett M; Wise LM; Mercer AA; Krause KL
Structure; 2015 Jul; 23(7):1199-213. PubMed ID: 26095031
[TBL] [Abstract][Full Text] [Related]
19. Engineered anti-inflammatory peptides inspired by mapping an evasin-chemokine interaction.
Darlot B; Eaton JRO; Geis-Asteggiante L; Yakala GK; Karuppanan K; Davies G; Robinson CV; Kawamura A; Bhattacharya S
J Biol Chem; 2020 Aug; 295(32):10926-10939. PubMed ID: 32471866
[TBL] [Abstract][Full Text] [Related]
20. Surface expression of CC- and CXC-chemokine receptors on leucocyte subsets in inflammatory joint diseases.
Brühl H; Wagner K; Kellner H; Schattenkirchner M; Schlöndorff D; Mack M
Clin Exp Immunol; 2001 Dec; 126(3):551-9. PubMed ID: 11737076
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
